Review
doi: 10.1097/FPC.0b013e3283349e84.
Cytochrome P450 2C9-CYP2C9
Affiliations
- PMID: 20150829
- PMCID: PMC3201766
- DOI: 10.1097/FPC.0b013e3283349e84
Item in Clipboard
Review
Cytochrome P450 2C9-CYP2C9
Pharmacogenet Genomics.
2010 Apr.
No abstract available
Similar articles
-
Association between the CYP2C9 polymorphism and the drug metabolism phenotype.Clin Chem Lab Med. 2004 Jan;42(1):72-8. doi: 10.1515/CCLM.2004.014. Clin Chem Lab Med. 2004. PMID: 15061384
-
Genetic polymorphism of the human cytochrome P450 2C9 gene and its clinical significance.Curr Drug Metab. 2009 Sep;10(7):781-834. doi: 10.2174/138920009789895480. Curr Drug Metab. 2009. PMID: 19925388 Review.
-
Genetic polymorphism of CYP2C9 in a Vietnamese Kinh population.Ther Drug Monit. 2005 Apr;27(2):208-10. doi: 10.1097/01.ftd.0000153402.91854.42. Ther Drug Monit. 2005. PMID: 15795654
-
Distribution of the major cytochrome P450 (CYP) 2C9 genetic variants in a Saudi population.Basic Clin Pharmacol Toxicol. 2011 Aug;109(2):111-4. doi: 10.1111/j.1742-7843.2011.00692.x. Epub 2011 Mar 28. Basic Clin Pharmacol Toxicol. 2011. PMID: 21371265
-
Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development.Curr Med Chem. 2009;16(27):3480-675. doi: 10.2174/092986709789057635. Epub 2009 Sep 1. Curr Med Chem. 2009. PMID: 19515014 Review.
Cited by
-
A physiome interoperability roadmap for personalized drug development.Interface Focus. 2016 Apr 6;6(2):20150094. doi: 10.1098/rsfs.2015.0094. Interface Focus. 2016. PMID: 27051513 Free PMC article.
-
Pharmacokinetics and Pharmacodynamics of Cenerimod, A Selective S1P1 R Modulator, Are Not Affected by Ethnicity in Healthy Asian and White Subjects.Clin Transl Sci. 2021 Jan;14(1):143-147. doi: 10.1111/cts.12873. Epub 2020 Sep 10. Clin Transl Sci. 2021. PMID: 32860737 Free PMC article. Clinical Trial.
-
Individualized versus Standardized Risk Assessment in Patients at High Risk for Adverse Drug Reactions (The IDrug Randomized Controlled Trial)-Never Change a Running System?Pharmaceuticals (Basel). 2021 Oct 18;14(10):1056. doi: 10.3390/ph14101056. Pharmaceuticals (Basel). 2021. PMID: 34681280 Free PMC article.
-
Effects of Cytochrome P450 Inhibition and Induction on the Phenotyping Metrics of the Basel Cocktail: A Randomized Crossover Study.Clin Pharmacokinet. 2016 Jan;55(1):79-91. doi: 10.1007/s40262-015-0294-y. Clin Pharmacokinet. 2016. PMID: 26123704 Free PMC article. Clinical Trial.
-
Inhibitory Interactions of Aspalathus linearis (Rooibos) Extracts and Compounds, Aspalathin and Z-2-(β-d-Glucopyranosyloxy)-3-phenylpropenoic Acid, on Cytochromes Metabolizing Hypoglycemic and Hypolipidemic Drugs.Molecules. 2016 Nov 12;21(11):1515. doi: 10.3390/molecules21111515. Molecules. 2016. PMID: 27845750 Free PMC article.
References
-
- Gray IC, Nobile C, Muresu R, Ford S, Spurr NK. A 2.4-megabase physical map spanning the CYP2C gene cluster on chromosome 10q24. Genomics. 1995;28:328–332. - PubMed
-
- Yasar U, Lundgren S, Eliasson E, Bennet A, Wiman B, de Faire U, Rane A. Linkage between the CYP2C8 and CYP2C9 genetic polymorphisms. Biochem Biophys Res Commun. 2002;299:25–28. - PubMed
-
- Garcia-Martin E, Martinez C, Tabares B, Frias J, Agundez JA. Interindividual variability in ibuprofen pharmacokinetics is related to interaction of cytochrome P450 2C8 and 2C9 amino acid polymorphisms. Clin Pharmacol Ther. 2004;76:119–127. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
